The All India Organisation of Chemists & Druggists (AIOCD) is calling on the government for immediate support for small chemists struggling with the transition to GST 2.0. The recent reduction in GST rates on medicines, while beneficial for consumers, has caused significant losses for retailers who purchased stock at higher tax rates. Many small chemists are ineligible for Input Tax Credit, and with fixed drug margins, they cannot absorb these losses. AIOCD has requested measures such as allowing the sale of old stock at previous MRPs for three months and a special relief package to prevent widespread closures, particularly in rural areas.
The All India Organisation of Chemists Druggists (AIOCD), which represents over 12.5 lakh chemists and distributors nationwide, has appealed to the government for immediate relief measures to support small retailers struggling with the ongoing shift to GST 2.0.
In a memorandum to Finance Minister
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to
CCI PRO
for unlimited access
Why Upgrade to
CCI PRO?
-
No Ads
-
WhatsApp Broadcasts
-
Daily E-Newsletter
-
Unlimited News Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
Buy CCI PRO Now
Already a PRO member?
Login here
for an ad-free experience.
FAQ :
GST 2.0 refers to the recent transition and changes in the Goods and Services Tax rates, specifically concerning medicines in this context.
Small chemists are struggling because the reduction in GST rates on medicines has left them with losses on unsold inventory purchased at higher tax rates. Many also cannot claim Input Tax Credit.
AIOCD is seeking permission to sell old stock at pre-revision MRPs for three months, a special relief package for affected retailers, and a moratorium on penal actions during the adjustment period.
The All India Organisation of Chemists & Druggists (AIOCD), representing over 12.5 lakh chemists and distributors nationwide, is making the appeal.
Without timely support, many small chemists, especially in rural and semi-urban areas, may be forced to close down, which could impact the last-mile availability of essential medicines.